COMP <GO>

IDXG vs NUR // RSI-14 & 200D SMA MOMENTUM

Interpace Biosciences Inc. (NASDAQ) VS. Nuran Wireless Inc. (NASDAQ) • 15-METRIC TALLY: IDXG 2 — NUR 0

▲ RSI-14 & 200D SMA MOMENTUM LEADER: IDXG

LAST: $5.72 (+15.56%) • MKT CAP: $23.2M

rsi-technicals

50.0

LAST: $0.68 (+0.95%) • MKT CAP: $9.0M

rsi-technicals

31.8

15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IDXG VS. NUR) EMERALD CELL = QUANTITATIVE EDGE

INSTITUTIONAL METRIC	IDXG	NUR	SPREAD (A - B)	ADVANTAGE	DEDICATED URL
Gross Profit Margin	62.30%	—	—	TIE	/gross-margins <GO>
Return on Invested Capital (ROIC)	16.20%	—	—	TIE	/roic <GO>
EV/EBITDA & P/E Valuation	4.7x	—	—	TIE	/valuation <GO>
Free Cash Flow Yield	23.60%	—	—	TIE	/fcf-yield <GO>
Operating Margin	10.50%	—	—	TIE	/operating-margins <GO>
Net Profit Margin	63.50%	—	—	TIE	/net-margins <GO>
Revenue Growth (YoY)	-17.50%	—	—	TIE	/revenue-growth <GO>
Dividend Yield & FCF Payout Safety	0.00%	0.00%	0.00	TIE	/dividend-safety <GO>
Altman Z-Score & Debt/Equity	—	—	—	TIE	/balance-sheet <GO>
Piotroski F-Score Quality	6/9	—	—	TIE	/piotroski-score <GO>
Options Implied Move & Put/Call Skew	—	—	—	TIE	/options-implied-move <GO>
RSI-14 & 200D SMA Momentum ACTIVE	50.0	31.8	+18.13	IDXG	/rsi-technicals <GO>
10Y Yield & FRED Macro Beta	—	—	—	TIE	/macro-sensitivity <GO>
Forward P/E Multiple	—	—	—	TIE	/forward-pe <GO>
Enterprise Scale & Market Cap	$23.2M	$9.0M	$14.2M	IDXG	/market-cap <GO>

5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY

FISCAL YEAR	IDXG REV	NUR REV	IDXG GROSS %	NUR GROSS %	IDXG FCF	NUR FCF
FY 2025	$38.7M	—	62.3%	—	$5.5M	—
FY 2024	$46.9M	—	63.8%	—	$3.8M	—
FY 2023	$40.0M	—	—	—	$3.8M	—

FRED MACRO REGIME CORRELATION COMPARISON PEARSON r

IDXG // BETA —

NUR // BETA —